InMed Pharmaceuticals (INM) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

INM InMed Pharmaceuticals

Watchlist

4.7435
+0.0935+2.01%

Trading Nov 22 10:30 ET

3.41MMarket Cap-618P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

InMed Pharmaceuticals Explores CBN for Skin Disease Treatment
TipRanksNov 20 16:18 ET
InMed Announces Publication of Study on Anti-Inflammation by Modulation of Endocannabinoid System
newsfileNov 19 07:30 ET
InMed Pharmaceuticals | 8-K: InMed Reports First Quarter Fiscal 2025 Financial Results and Provides Business Update
SECNov 15 11:28 ET
Express News | InMed Pharmaceuticals Shares Are Trading Lower After the Company Reported a Year-over-year Decrease in Q4 EPS Results
BenzingaNov 15 08:41 ET
InMed Pharmaceuticals Makes Progress on Alzheimer's Drug
TipRanksNov 14 18:08 ET
InMed Pharmaceuticals GAAP EPS of -$2.17, Revenue of $1.26M
Seeking AlphaNov 14 17:44 ET

Comments

Broke Trader

20 hours ago

$InMed Pharmaceuticals (INM.US)$ this stock needs volume

Jaguar8

Nov 20 22:08

These post RS stocks which didn’t rally yet will be on my watchlist too. Most are microfloats. Don’t expect a massive rally post RS ok.

$Wheeler Real Estate Investment Trust Inc (WHLR.US)$ $MSP Recovery (LIFW.US)$ $Signing Day Sports (SGN.US)$ $Bluejay Diagnostics (BJDX.US)$ $InMed Pharmaceuticals (INM.US)$

Trytosaveabit

Nov 19 06:38

Update

$InMed Pharmaceuticals (INM.US)$ InMed Announces Publication of Study on Anti-Inflammation by Modulation of Endocannabinoid System
newsfile· 5 mins ago
Cannabinol modulates distinct endocannabinoid system elements and exerts anti-inflammatory effectsSupports therapeutic potential of cannabinol for inflammatory skin diseases such as psoriasis, atopic dermatitis and pruritusAnti-inflammatory effects of cannabinol show potential for therapeutic and cosmetic application